NJBIZ Honors Integra LifeSciences as One of New Jersey’s Top Fifty Fastest Growing Companies


Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it was honored as one of New Jersey's Top Fifty Fastest Growing Companies by NJBIZ, one of New Jersey's leading statewide business newspaper. NJBIZ revealed the list of the top fifty New Jersey businesses that have made significant contributions to the growth, strength and success of New Jersey during its award ceremony held at The Palace in Somerset Park on Monday, November 16, 2009. Integra LifeSciences Holdings Corporation (Nasdaq:IART) was ranked #10 on this year's list.

We are very honored by this independent recognition of Integra's business growth and success," said Stuart Essig, Integra's CEO. "Integra celebrates its 20th anniversary this year and this is a testament to the dedication and talents of our employees and the vision of our management team."

In order to be eligible for nomination, companies needed to be for-profit entities headquartered in New Jersey and show revenue of at least $500,000 in each of the fiscal years ending 2005, 2006, 2007 and 2008 and show revenue growth in 2008, as compared to 2005 (a four year period).

Presenting sponsor, Rothstein Kass, calculated the nominations and then ranked the companies according to revenue growth over the four-year period of 2005-2008. Both dollar and percentage increases were taken into consideration. This ranking formula led to recognition of the 2009 New Jersey's Fifty Fastest Growing Companies consisting of both large and small companies.

In addition to the awards ceremony on November 16, 2009, the Top Fifty Fastest Growing Companies are profiled in a special supplement to the November 23, 2009 issue of NJBIZ. The complete list of honorees is published in ranked order, along with information on each company's financial growth.

The New Jersey's Finest Fifty Fastest Growing Companies event is a program of NJBIZ and is presented by Rothstein Kass. Major sponsors of this event are Lowenstein Sandler PC, PNC Bank, Extensis and CIGNA.

Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Integra's products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information visit www.integra-ls.com.

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2008 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.